MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11102-025-01574-5

Медицинская библиотека · Pituitary · 2025

Silent growth hormone pituitary adenomas: a single-center study.

Xiao Tongxin, Mao Xinxin, Zheng Xueqing, Li Ran, Wang Linjie, Yao Yong, Deng Kan, Gong Fengying, Pan Hui, Lu Lin, Zhu Huijuan, Duan Lian

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: To characterize the clinicopathological features and metabolic profiles of silent growth hormone pituitary adenomas (SGH-PAs).

METHODS

The single-center retrospective study identified SGH-PAs from 1387 surgically treated non-functioning PAs at Peking Union Medical College Hospital (2019-2023). Controls included 407 consecutive cases with non-functioning gonadotropin pituitary adenomas (NFG-PAs) and 90 age and gender-matched acromegaly patients. Baseline and postoperative hormonal assessments, pituitary imaging features, pathological classification, metabolic comorbidity, and follow-up outcome were collected and analyzed.

RESULTS

45 cases of SGH-PA (3.2%) were identified from 1387 non-functioning PAs. The pathological subtypes included 18 (40%) acidophil stem cell adenomas, 11(24%) immature PIT1-lineage tumors, 5 sparsely granulated GH tumors, 5 mammosomatotroph tumors, 4 mature plurihormonal PIT1 lineage tumors, and 2 plurihormonal pituitary tumors. Compared to controls, SGH-PAs showed modestly elevated proliferation (median Ki-67 3% vs. 2% in both acromegaly [p = 0.002] and NFG-PAs [p = 0.011]) without outstanding increases in tumor invasiveness (Knosp 3-4: 20-30% across groups) at baseline or 2-year recurrence. Baseline metabolic comorbidities paralleled NFG-PA profiles for hypertension (22%) and diabetes (8.9%), with reduced dyslipidemia prevalence (17.8% vs. 33.4%, p = 0.049). No case of SGH-PAs transforming into acromegaly was confirmed during 77 person-years of follow-up.

CONCLUSIONS

SGH-PAs represent approximately 3% of nonfunctioning PAs undergoing surgery. Multiple anterior pituitary hormones are commonly co-expressed. These tumors may be more proliferative, but the baseline aggressiveness in radiology and short-term recurrence rates are similar.

Для цитирования: Xiao Tongxin, Mao Xinxin, Zheng Xueqing, Li Ran, Wang Linjie, Yao Yong, Deng Kan, Gong Fengying, Pan Hui, Lu Lin, Zhu Huijuan, Duan Lian. Silent growth hormone pituitary adenomas: a single-center study.. Pituitary. 2025. DOI: 10.1007/s11102-025-01574-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.